Terms & Conditions

1. About Curigo Pharma

The Curigo Pharma website and pharmacy service are owned and operated by FW Assets Management Ltd, company number 14756636.

Registered office:

13 Aqueduct Street

Preston

Lancashire

PR1 7JN

United Kingdom

Our proposed pharmacy premises are:

Curigo Pharma

3 Wilkinson Walk

Blackburn

Lancashire

BB2 7GY

United Kingdom

GPhC pharmacy premises registration: Application pending.

Curigo Pharma will not begin supplying medicines requiring registration of the pharmacy premises until registration has been confirmed by the General Pharmaceutical Council (GPhC).

The Superintendent Pharmacist is:

Samir Haroon Patel

GPhC registration number: 2084333

These Terms & Conditions govern your use of the Curigo Pharma website and the services provided through it.

By using our website, creating an account, submitting an online consultation or requesting a service, you agree to these Terms & Conditions.

These Terms should be read alongside our Privacy Policy, Cookie Policy, Delivery Policy, Returns and Refunds Policy, Complaints Policy and other policies displayed on our website.

2. Our Clinical Services

Curigo Pharma provides private pharmacist-led healthcare services.

At launch, Curigo Pharma's treatment services will operate under appropriate Patient Group Directions (PGDs).

Every request for treatment is clinically assessed. A pharmacist will review the information provided during your consultation and assess your eligibility for treatment against the requirements of the relevant PGD.

All PGD services will be provided by an appropriately qualified and authorised pharmacist who is also a Pharmacist Independent Prescriber registered with the General Pharmaceutical Council (GPhC).

Treatment is never guaranteed. Treatment will only be supplied where the pharmacist is satisfied that you meet the requirements of the relevant PGD; sufficient information is available to make a safe clinical decision; the medicine is suitable and clinically appropriate; and supply is lawful and professionally appropriate.

Where you do not meet the requirements of the relevant PGD, treatment will not be supplied under that PGD and you will be advised of appropriate next steps where necessary.

3. Patient Group Directions (PGDs)

A Patient Group Direction (PGD) is a legal framework that allows an appropriately qualified and authorised healthcare professional to supply and/or administer specified medicines to eligible patients who meet the defined requirements of the PGD without an individual prescription.

Patients requesting treatment through a PGD service must meet all applicable requirements of that PGD.

If you do not meet the relevant requirements, Curigo Pharma cannot supply treatment under that PGD.

Payment for a service or completion of a consultation does not guarantee that treatment will be supplied.

4. Independent Prescribing

Curigo Pharma will not initially provide treatment through an independent prescribing service.

The pharmacist providing Curigo Pharma's PGD services is also a qualified Pharmacist Independent Prescriber.

Independent prescribing may be introduced for appropriate services in the future. Before an independent prescribing service is introduced, Curigo Pharma will ensure that the service operates within applicable legal, professional and regulatory requirements and that relevant information about the prescribing service and prescriber is made available on the website.

5. Where Our Services and Medicines Are Provided

All Curigo Pharma clinical services will be operated from Curigo Pharma, 3 Wilkinson Walk, Blackburn, Lancashire, BB2 7GY, United Kingdom.

Medicines supplied directly by Curigo Pharma will be prepared, assembled and labelled where required, and supplied from these pharmacy premises.

Curigo Pharma does not currently use another registered pharmacy to prepare, assemble or label medicines on its behalf.

6. Eligibility

Certain services are subject to specific eligibility requirements, which may include age, medical history, current medicines, allergies, clinical suitability and other requirements of the relevant PGD.

Curigo Pharma may request evidence of identity, age or other information where necessary.

Our services are primarily intended for patients located within the United Kingdom.

Curigo Pharma may refuse a service where eligibility requirements are not satisfied or where treatment cannot be provided safely or lawfully.

7. Your Account

Certain services may require you to create a secure account.

You must provide accurate, truthful, complete and current information.

You must not create multiple accounts to circumvent clinical decisions or restrictions, impersonate another person or allow another person to use your account inappropriately.

You are responsible for maintaining the security of your account and login details and should notify Curigo Pharma if you believe your account has been compromised.

8. Identity Verification

Curigo Pharma may verify your identity before providing a service or supplying treatment.

Verification may include confirmation of personal details, photographic identification, proof of address, video consultation or other appropriate checks.

Treatment may be delayed or refused where your identity cannot be satisfactorily established.

9. Online Consultations

Consultations may take place through an online questionnaire, secure messaging, telephone or video consultation, depending on the service and the pharmacist's professional judgement.

The purpose of the consultation is to obtain sufficient information to determine whether treatment can be safely and appropriately supplied under the relevant PGD.

Completion of a consultation does not guarantee treatment.

The pharmacist may request additional information or supporting evidence before making a clinical decision.

10. Your Responsibilities

You must provide accurate, complete and truthful information during your consultation.

This includes, where relevant: your medical conditions and medical history; current medicines; allergies and previous adverse drug reactions; pregnancy or breastfeeding status; previous or current treatment; relevant investigation results; and any other information requested during the consultation.

You must tell us if relevant information changes.

Providing false, misleading or incomplete information may result in treatment being delayed or refused and may compromise your safety.

11. Clinical Decision-Making

All clinical decisions are made using the professional judgement of the responsible pharmacist and in accordance with applicable legislation, professional standards, the relevant PGD, recognised clinical guidance and the individual circumstances of the patient.

The pharmacist may approve treatment where the relevant requirements are met; request further information; decline treatment; recommend an alternative course of action where appropriate; or refer or signpost you to another healthcare provider.

Patient preference, previous treatment or payment for a consultation cannot override a clinical decision.

12. Communication With Your GP and Other Healthcare Professionals

Where clinically appropriate, Curigo Pharma may communicate relevant information to your GP or another healthcare professional involved in your care.

This may include information about medicines supplied, clinically significant findings, adverse drug reactions, safeguarding concerns or other information necessary to support safe continuity of care.

Information will be handled in accordance with applicable data protection requirements and our Privacy Policy.

There may be circumstances where information can be shared without consent where this is permitted or required by law or necessary to protect you or another person from serious harm.

13. Medicines

Medicines will only be supplied where the responsible pharmacist is satisfied that supply is clinically appropriate, lawful and permitted under the relevant service.

Before supply, Curigo Pharma may carry out additional checks including identity verification; consultation and medical-history review; current medication and interaction checks; allergy and contraindication checks; previous Curigo consultation and supply history; frequency or quantity of previous requests; safeguarding checks; and other checks considered appropriate for patient safety.

Curigo Pharma may delay or refuse supply where concerns cannot be satisfactorily resolved.

Medicine availability cannot be guaranteed.

14. Responsible Use of Medicines

Medicines supplied by Curigo Pharma are intended only for the patient for whom they have been supplied.

You must not share medicines with another person.

You should use medicines according to the instructions provided by the pharmacist, the medicine label and the Patient Information Leaflet.

You should seek appropriate medical advice if you experience suspected side effects or have concerns about your treatment.

Serious or life-threatening reactions require urgent medical attention.

15. Multiple Accounts, Duplicate Requests and Misuse

Curigo Pharma may investigate repeated, duplicate or potentially inappropriate requests for medicines.

This may include reviewing previous consultations and supplies and identifying multiple accounts or repeated requests associated with the same patient, address, contact information or other relevant information.

Treatment may be refused where Curigo Pharma reasonably believes that medicines are being obtained fraudulently, inappropriately, for misuse or for supply to another person.

16. Orders and Payment

Submitting an order or making payment does not guarantee that treatment will be approved or supplied.

An order requiring clinical assessment will only be approved after the necessary clinical, legal and professional checks have been completed.

Prices are displayed in pounds sterling (£).

Payment will normally be required before a service or medicine is supplied.

Payments may be processed by authorised third-party payment providers.

If treatment cannot be supplied, any refund due will be handled in accordance with these Terms and our Returns and Refunds Policy.

17. Cancellation and Refunds

You may request cancellation before an order has been processed or dispatched.

Cancellation and return rights relating to medicines may be restricted once a medicine has been prepared or supplied because of legal requirements and patient-safety considerations.

Medicines cannot normally be accepted for return for reuse once supplied, even if unopened.

Where an incorrect, faulty or damaged item has been supplied, contact Curigo Pharma as soon as reasonably practicable.

Nothing in these Terms affects your statutory consumer rights.

Further information is available in our Returns and Refunds Policy.

18. Delivery

Medicines and other products will be delivered using the delivery methods displayed or communicated by Curigo Pharma.

Delivery times are estimates unless expressly stated otherwise.

You are responsible for providing an accurate delivery address and for ensuring medicines are received and stored appropriately.

Where a medicine requires particular storage conditions, you must follow the instructions supplied.

Curigo Pharma is not responsible for deterioration caused by incorrect storage after successful delivery.

Further information is available in our Delivery Policy.

19. Medicine Recalls and Safety Alerts

Where a medicine supplied by Curigo Pharma becomes subject to a recall or significant safety alert, we may contact affected patients using the contact information provided to us.

You should follow any instructions provided in relation to a medicine recall or safety alert.

You are responsible for keeping your contact details up to date.

20. Emergency Medical Conditions

Curigo Pharma does not provide an emergency medical service.

Our online services should not be used for medical emergencies or where immediate face-to-face assessment is required.

If you believe you are experiencing a medical emergency, call 999 or attend an Accident & Emergency department immediately.

Where urgent but non-emergency medical advice is required, contact NHS 111 or another appropriate healthcare service.

Do not delay seeking urgent medical attention while waiting for a response from Curigo Pharma.

21. Clinical Records and Your Information

Curigo Pharma maintains appropriate records relating to the services it provides, including consultation information, clinical assessments, medicines supplied, communications and relevant follow-up information.

Personal information will be collected, used, stored and protected in accordance with applicable data protection requirements.

Further information is available in our Privacy Policy and Information Governance information.

22. Website Use and Security

You must use the Curigo Pharma website lawfully and responsibly.

You must not attempt to interfere with the website or its security, introduce malicious software, obtain unauthorised access, provide fraudulent information or use the website to obtain medicines unlawfully.

Curigo Pharma may suspend or terminate access where reasonably necessary to protect patients, staff, the website or comply with legal and regulatory obligations.

We cannot guarantee that the website will always be uninterrupted or error-free and may temporarily suspend access for maintenance, security or technical reasons.

23. Intellectual Property

Unless otherwise stated, the content of the Curigo Pharma website, including its branding, written content, graphics and other materials, is owned by or licensed to Curigo Pharma.

Website content must not be reproduced or commercially exploited without permission except where permitted by law.

24. Website Information

Curigo Pharma takes reasonable care to ensure information published on its website is accurate and appropriate at the time of publication.

General website information is not a substitute for an individual clinical assessment or personalised medical advice.

Clinical guidance and regulatory requirements may change and website information may therefore be updated from time to time.

25. Liability and Consumer Rights

Curigo Pharma will provide its pharmacy and healthcare services with reasonable care and skill and in accordance with applicable legal and professional requirements.

Nothing in these Terms excludes or limits liability where it would be unlawful to do so, including liability for death or personal injury caused by negligence, fraud or fraudulent misrepresentation.

Nothing in these Terms excludes or restricts statutory consumer rights that cannot lawfully be excluded.

26. Complaints and Feedback

We welcome feedback about our services.

If you have a concern or complaint, please contact Curigo Pharma so that we can investigate and respond appropriately.

Our full Complaints Policy explains how to submit a complaint, how complaints are managed and the options available if you remain dissatisfied.

Nothing in these Terms prevents you from raising a concern with an appropriate regulatory body where applicable.

27. Contact Details

For questions about these Terms, our services or your treatment, please contact:

Curigo Pharma

3 Wilkinson Walk

Blackburn

Lancashire

BB2 7GY

United Kingdom

Email: info@curigopharmacy.co.uk

Telephone: 07852 753696

28. Changes to These Terms

We may update these Terms where necessary to reflect changes in legislation, regulatory requirements, professional guidance, our services or the operation of our website.

The current version will be published on the Curigo Pharma website with the applicable effective or last-updated date.

29. Governing Law

These Terms are governed by the laws of England and Wales.

Any dispute will be dealt with by the courts having jurisdiction under applicable law. Nothing in these Terms affects any rights you may have under applicable consumer protection legislation.

30. Regulatory Information

Curigo Pharma is committed to operating in accordance with applicable pharmacy legislation, medicines legislation, professional standards and regulatory requirements.

Further information about the pharmacy owner, Superintendent Pharmacist, GPhC registration status and how to check professional registration is available on our Regulatory Information page.